Retrophin (RTRX) Said to Consider Bid for Raptor Pharma (RPTP) - Bloomberg

August 18, 2016 6:36 AM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Retrophin (NASDAQ: RTRX) is considering an acquisition of Raptor Pharma (NASDAQ: RPTP), according to Bloomberg, citing sources.

Raptor has also attracted interest from other drugmakers, the report said.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Hot M&A, Mergers and Acquisitions, Rumors, Trader Talk

Related Entities

Definitive Agreement

Add Your Comment